Detalles de la búsqueda
1.
Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials.
CNS Spectr
; 25(3): 352-362, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31199210
2.
What is the overlap between subjective and objective cognitive impairments in MDD?
Ann Clin Psychiatry
; 30(3): 176-184, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30028891
3.
Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder.
Psychiatry Clin Neurosci
; 72(2): 64-72, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28858412
4.
Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.
CNS Spectr
; 21(5): 367-378, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575433
5.
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
J Sex Med
; 12(10): 2036-48, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26331383
6.
A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
Hum Psychopharmacol
; 29(1): 64-72, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24424707
7.
A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
Int J Neuropsychopharmacol
; 16(2): 313-21, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22963932
8.
Patient Centricity: Design and Conduct of Clinical Trials in Orphan Diseases: Third of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development.
Innov Clin Neurosci
; 20(1-3): 25-31, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122576
9.
Ecopipam for Tourette Syndrome: A Randomized Trial.
Pediatrics
; 151(2)2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628546
10.
Consistency checks to improve measurement with the Hamilton Rating Scale for Anxiety (HAM-A).
J Affect Disord
; 325: 429-436, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638966
11.
Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D).
J Affect Disord
; 302: 273-279, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101520
12.
A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia.
Schizophr Res
; 204: 289-294, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190165
13.
Consistency checks to improve measurement with the Montgomery-Asberg Depression Rating Scale (MADRS).
J Affect Disord
; 256: 143-147, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31176186
14.
Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial.
J Affect Disord
; 221: 275-282, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28662460
15.
A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults.
Eur Neuropsychopharmacol
; 26(6): 979-93, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27139079
16.
A Population Pharmacokinetic-Pharmacodynamic Meta-Analysis of Vortioxetine in Patients with Major Depressive Disorder.
Basic Clin Pharmacol Toxicol
; 118(5): 344-55, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26525043
17.
A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
J Clin Psychiatry
; 76(5): 575-82, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26035185
18.
A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
J Clin Psychiatry
; 76(5): 583-91, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26035186
19.
Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Int Clin Psychopharmacol
; 30(5): 255-64, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26020712
20.
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
Neuropsychopharmacology
; 40(8): 2025-37, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25687662